Actuate Therapeutics is currently advancing a novel best-in-class GSK-3β inhibitor into the clinic for oncology and fibrotic diseases Across multiple institutions, researchers have conducted studies of 9-ING-41 with compelling results. The IND was approved in 1Q18 and a groundbreaking Phase 1/2 study is ready to initiate in 2018.
Employees: 11-50
Total raised: $28.2M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | Tech Coast... | techcoasta... |
| - | SeedFolio | seedfolio.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.11.2019 | Series B | $6.5M | - |
| 17.05.2019 | Series B | $21.7M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 23.02.2023 | Tempus Forms Multi-omics Collaboration With Actuate Therapeu... | What You Should Know: – Tempus, the $10B artificial intelligence and precision medicine company, an... | hitconsult... |
| 28.10.2021 | Actuate Therapeutics Announces Primary Endpoint Met In Phase... | CHICAGO and FORT WORTH, Texas (PRWEB) October 28, 2021 Actuate Therapeutics, Inc. (Actuate), a clin... | prweb.com/... |
| 05.08.2021 | Actuate Therapeutics Announces FDA Fast Track Designation fo... | CHICAGO, and FORT WORTH, Texas (PRWEB) August 05, 2021 Actuate Therapeutics, Inc. (Actuate), a clin... | prweb.com/... |
| 13.11.2019 | Actuate Therapeutics Closes $6.5M Series B-3 Financing Round | Actuate Therapeutics, Inc., a Chicago, IL- and Forth Worth, TX-based clinical stage biopharmaceutica... | finsmes.co... |
| 12.11.2019 | Actuate Therapeutics Completes $6.5 Million Series B-3 Finan... | Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced it has raise... | citybizlis... |
| 20.05.2019 | Daily funding roundup - May 20th, 2019 | Daisie landed $2.5M; Arris Composites closed $10M; Health at Scale secured $16M; Modsy raised $37M ... | vator.tv/n... |
| 20.05.2019 | Term Sheet — Monday, May 20 | NOT JUST A TAX BREAK There’s a new opportunity fund in town. Jim Sorenson’s Catalyst, a private equ... | fortune.co... |
| 17.05.2019 | Actuate Therapeutics Completes $21.7M Series B Financing | Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced it has raise... | citybizlis... |
| 17.05.2019 | Actuate Therapeutics Completes $21.7M Series B Financing | Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced it has raise... | archive.ci... |
| 17.05.2019 | Actuate Therapeutics Closes $21.7M Series B Financing | Actuate Therapeutics, Inc., a Fort Worth, TX-based clinical stage biopharmaceutical company, raised ... | finsmes.co... |
Show more